Columbia Care Introduces Hedy, a New Cannabis-Infused Edibles Brand

Hedy will become the unifying brand for allColumbia Careedible products across the country

NEW YORK--(BUSINESS WIRE)--Oct. 6, 2022-- (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in theU.S., announced it has launched its new cannabis-infused edibles brand, Hedy, in six markets. A variety of fast-acting chocolates and gummies are now available inArizona,Colorado,Delaware,Massachusetts,MissouriandVirginia.

“We are so excited to bring Hedy to life and share with our patients and customers across the country. Our team wanted to create a brand, as well as a bright, fun and inviting visual representation that truly reflects the uplifting edibles experience,” said BJ Carretta, SVP of Brands,Columbia Care. “Everything from the packaging to the flavors, and eventually the various forms underneath the brand, are all part of this authentic interaction with Hedy. We developed the brand in coordination with our cultivation and marketing teams, using insights generated from our unique technological platforms, such as Forage, that help us better understand what our community is looking for. We believe this is the right product to meet our patients and customers where they are in their cannabis journey, with an approachable form factor that is of the highest quality and designed to provide a consistent experience, no matter the market.”

In its first six markets, Hedy gummies will be available in three flavors: cherry lime, green apple and watermelon.Coloradohas also launched chocolate drops. The 5mg or 10mg THC gummies come in packages of 10 or 20, depending on the market, and are powered by leading edibles ingredient company Azuca and its fast-acting TiME INFUSION™ formulations to provide quick-onset in 5-15 minutes.

In the coming months, the Company will introduce more options, and will have Hedy available in more markets. Additionally, existingColumbia Careedible brands such as NectarBee, will be converting to the Hedy brand over time.

For more information about Hedy, visit

AboutColumbia Care
Columbia Careis one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions.Columbia Careoperates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.Columbia Careis one of the original multi-state providers of medical cannabis in theU.S.and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, Amber and Platinum Label CBD. For more information onColumbia Care, please visit

Caution Concerning Forward-Looking Statements
This press release contains certain statements that constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. Forward-looking statements or information contained in this release include, but are not limited to, statements or information with respect to the Company’s ability to execute on retail, wholesale, brand and product initiatives. These forward-looking statements or information, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. These risks, uncertainties and other factors include, among others, favorable operating and economic conditions; obtaining and maintaining all required licenses and permits; favorable production levels and sustainable costs from the Company’s operations; and the level of demand for cannabis products, including the Company’s products sold by third parties. In addition, securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Form 10 datedMay 9, 2022, filed with the applicable securities regulatory authorities and described from time to time in documents filed by the Company with Canadian andU.S.securities regulatory authorities.

Investor Contact
Lee Ann Evans
Capital Markets

Media Contact
Lindsay Wilson

Source:Columbia Care Inc.

<< Back to Press Releases